3-TYP - SIRT3 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第1頁(yè)
3-TYP - SIRT3 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第2頁(yè)
3-TYP - SIRT3 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第3頁(yè)
3-TYP - SIRT3 抑制劑 - 生命科學(xué)試劑 - MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemE3-TYPCat. No.: HY-108331CAS No.: 120241-79-4分式: CHN分量: 146.15作靶點(diǎn): Sirtuin作通路: Cell Cycle/DNA Damage; Epigenetics儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 100 mg/mL (684.23 mM; Need ul

2、trasonic)Ethanol : 16.67 mg/mL (114.06 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 6.8423 mL 34.2114 mL 68.4229 mL5 mM 1.3685 mL 6.8423 mL 13.6846 mL10 mM 0.6842 mL 3.4211 mL 6.8423 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。體內(nèi)實(shí)驗(yàn)請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍?,配制前?qǐng)先配制澄清的儲(chǔ)備液,再依次添加

3、助溶劑(為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)天使;澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請(qǐng)依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 3.25 mg/mL (22.24 mM); Clear solution2. 請(qǐng)依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 3.25 mg/mL (22.24 mM); Clear solution3. 請(qǐng)依序添加每種溶劑: 1

4、0% DMSO 90% corn oil1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemESolubility: 3.25 mg/mL (22.24 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 3-TYP種選擇性的 SIRT3 抑制劑,IC50 值為 16 nM, 對(duì) SIRT1 和 SIRT2 的選擇性強(qiáng),IC50 值分別為 88nM 和 92 nM。IC50 & Target SIRT3 SIRT1 SIRT216 nM (IC50) 88 nM (IC50) 92 nM (IC50)體外研究 3-TY

5、P inhibits melatonin-enhanced SIRT3 activity but does not affect SIRT3 protein expression. 3-TYPpretreatment reverses the protective effects of melatonin on cadmium (Cd)-induced mitochondrial-derivedO2 production and autophagic cell death. 3-TYP significantly attenuates melatonin-induced increases i

6、ndeacetylated-SOD2 expression and SOD2 activity in HepG2 cells exposed to Cd 1.體內(nèi)研究 3-TYP (50 mg/kg, i.p.) does not significantly influence the LVEF, LVFS, infarct size, serum LDH levels,apoptosis, and oxidative stress compared with those of the Sham group. Moreover, 3-TYP has little effect ongp91ph

7、ox, Nrf2, NQO 1, Bax, Bcl-2, Caspase-3, and cleaved Caspase-3 expression levels, compared withthe Sham group. 3-TYP significantly decreases SIRT3 activity and increases the acetylation of SOD2compared with that in the control group, without influencing SIRT3 expression. 3-TYP attenuates thecardiopro

8、tective effects of melatonin by decreasing the LVEF and LVFS after 24 hour of reperfusion. 3-TYPalso increases the infarct size, serum LDH levels, and apoptotic ratio compared with those in the IR+Melgroup 2.PROTOCOLCell Assay 1 Cell viability is analyzed using Cell Counting Kit-8. Briefly, 1104 cel

9、ls are inoculated into 96-well plates. Afterbeing treated, 90 L of medium and 10 L of CCK-8 solution are added to each well. The cells are thenincubated at 37C for 2 h. After incubation, the absorption at 450 nm is measured using an Infinite M200Microplate Reader. The results are expressed as a perc

10、entage of the control. The cell death is alsoevaluated using the trypan blue assay. HepG2 cells are plated in the 6-well plates (5105 cells per well) andincubated for 24 h. After being treated with Cd or melatonin, the cells are detached with 300 L trypsin-EDTAsolution. The mixture of detached cells

11、 is centrifugated at 300 g for 5 min. Then, the residue is combined with800 L trypan blue solution and dispersed. After 3 min staining, cells are counted using an automated cellcounter. The dead cells are stained with the blue color. Cell mortality (%) is expressed as percentage of thedead cell numb

12、er/the total cell number.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal In brief, male C57BL/6 mice are anesthetized with 2% isoflurane, and myocardial ischemia is produced byAdministration 2 temporarily exteriorizing the heart via a left thorac

13、ic incision and placing a 6-0 silk suture slipknot around theleft anterior descending coronary artery. After 30 minutes of myocardial ischemia, the slipknot is released,and the myocardium is reperfused for 3 hour (for western blot analysis and oxidative stress measurement) or2/3 Master of Small Mole

14、cules 您邊的抑制劑師www.MedChemE24 hour (for cardiac function, apoptotic index and infarct size determination). Sham-operated mice undergothe same surgical procedures except the suture placed under the left coronary artery is not tied. Ten minutesbefore reperfusion, mice are randomized to receive either ve

15、hicle (1% ethanol) or melatonin (20 mg/kg) byintraperitoneal injection. C57BL/6 mice are randomly divided into the following groups: (i) Sham group: miceunderwent the sham operation and are treated with vehicle (1% ethanol); (ii) Mel group: mice are treated withmelatonin (20 mg/kg via intraperitonea

16、l injection); (iii) IR+V group: mice underwent the MI/R operation andare treated with vehicle (1% ethanol); (iv) IR+Mel group: mice underwent the MI/R operation and are treatedwith melatonin (20 mg/kg via intraperitoneal injection 10 minutes before reperfusion); (v) IR+Mel+3-TYPgroup: mice are pretr

17、eated with 3-TYP (3-TYP is intraperitoneally injected at a dose of 50 mg/kg every 2 daysfor a total of three doses prior to the MI/R surgery), subjected to the MI/R operation, and treated withmelatonin (20 mg/kg via intraperitoneal injection 10 minutes before reperfusion); and (vi) IR+3-TYP group:mi

18、ce are pretreated with 3-TYP and then subjected to the MI/R operation.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Cell Physiol Biochem. 2017;44(6):2212-2227.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Pi H, et al. SIRT3-SOD2-mROS-dependent autophagy in cadmium-ind

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論